# Methylation Biomarkers for Pioneering Early Esophageal Cancer Detection

> **NCT06895551** · — · COMPLETED · sponsor: **Singlera Genomics Inc.** · enrollment: 1069 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06895551
- **Lead sponsor:** Singlera Genomics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2024-05-01
- **Final completion:** 2025-02-20
- **Target enrollment:** 1069 (ACTUAL)
- **Last updated:** 2025-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06895551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06895551, "Methylation Biomarkers for Pioneering Early Esophageal Cancer Detection". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06895551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*